Hudson Bay Capital Management
ARMP icon

Hudson Bay Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History

Hudson Bay Capital Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Hold
17,584
– – ﹤0.01% 1150
2026
Q1 		$180K Buy
+17,584
New +$148K ﹤0.01% 1117
2016
Q3 		– Sell
-1,704
Closed -$370K – 433
2016
Q2 		$370K Buy
+1,704
New +$588K 0.01% 319

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Hudson Bay Capital Management's ARMP Position: Q2 2026 in Review

Hudson Bay Capital Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 17,584 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Hudson Bay Capital Management first reported a position in ARMP in Q2 2016 and has held it in 3 quarters since. The position peaked at $370K in Q2 2016. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Hudson Bay Capital Management held 17,584 shares of Armata Pharmaceuticals worth $114K as of Q2 2026.
  • Hudson Bay Capital Management left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #1150 holding.
  • Hudson Bay Capital Management first reported a position in Armata Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Armata Pharmaceuticals position peaked at $370K in Q2 2016.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.